Pharma-Bio Serv, Inc. (OTCMKTS:PBSV – Get Free Report)’s share price passed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $0.92 and traded as low as $0.65. Pharma-Bio Serv shares last traded at $0.75, with a volume of 14,159 shares changing hands.
Pharma-Bio Serv Stock Down 12.6 %
The stock has a fifty day moving average of $0.88 and a two-hundred day moving average of $0.92. The stock has a market cap of $17.22 million, a price-to-earnings ratio of 25.01 and a beta of 0.51.
Pharma-Bio Serv (OTCMKTS:PBSV – Get Free Report) last released its quarterly earnings data on Monday, March 18th. The company reported ($0.01) EPS for the quarter, missing the consensus estimate of $0.02 by ($0.03). Pharma-Bio Serv had a net margin of 4.05% and a return on equity of 3.95%. The company had revenue of $2.38 million during the quarter, compared to analysts’ expectations of $5.00 million. Equities research analysts anticipate that Pharma-Bio Serv, Inc. will post 0.08 EPS for the current fiscal year.
About Pharma-Bio Serv
Pharma-Bio Serv, Inc operates as a compliance and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company provides technical compliance consulting services comprising regulatory compliance, validation, technology transfer, engineering, project management, and process support for the pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies.
Recommended Stories
- Five stocks we like better than Pharma-Bio Serv
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- United Airlines Soars on Earnings Beat
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- J.B. Hunt Hits the Skids: Lower Prices to Come
- Conference Calls and Individual Investors
- Predicting a Bear Market: 7 Signs and Why it’s Tough to Do
Receive News & Ratings for Pharma-Bio Serv Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharma-Bio Serv and related companies with MarketBeat.com's FREE daily email newsletter.